Dimension Capital Management LLC Curis Inc Transaction History

Dimension Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 01, 2023	BUY	$0.57 - $0.99 $59,849 - $103,950	105,000 New	105,000 $87,000
Q2 2023 Aug 14, 2023	BUY	$0.57 - $0.99 $45,599 - $79,200	80,000 Added 61.54%	210,000 $174,000
Q2 2022 Aug 12, 2022	BUY	$0.71 - $2.43 $14,200 - $48,600	20,000 Added 18.18%	130,000 $128,000
Q1 2022 May 13, 2022	BUY	$2.31 - $5.13 $254,100 - $564,300	110,000 New	110,000 $262,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Dimension Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dimension Capital Management LLC with notifications on news.